Michael Butscheidt joined the Board of Cardiac Implants in 2013 and brought his vast experience in the medical device industry with him. He is a former executive at St. Jude Medical, a leading global medical device manufacturer in heart failure devices, atrial fibrillation, and cardiac rhythm management, acquired by Abbott in 2017.